Healthcare Vivo Capital Leads $50M Series B Round In Chinese CRO Firm dMed Biopharmaceutical October 16, 2019 — 17:50
Fund News CITIC M&A Fund, Legend Capital Lead $280M Investment In Pharmaron December 14, 2015 — 11:20